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Purpose: We sought to identify the genetic defect in a large, five-generation Chinese family with autosomal dominant
progressive polymorphic congenital coronary cataracts and to examine the clinical features in detail.
Methods: Clinical and ophthalmologic examinations were conducted on family members. All members were genotyped
with microsatellite markers at loci previously associated with cataracts. Two-point LOD scores were calculated using a
linkage package after genotyping. A mutation was detected by direct sequencing and verified by denaturing high-
performance liquid chromatography (DHPLC).
Results: Clinical observations showed that all affected family members had progressive polymorphic coronary cataracts.
Linkage analysis was obtained at markers, D22S303 (LOD score [Z]=2.11, recombination fraction [θ]=0.0) and D22S1167
(Z=1.20, θ=0.0). Haplotype analysis indicated that the cataract gene was closely linked with these two markers. Sequencing
the βB-crystallin gene (CRYBB2) revealed a C → T transition in exon 6, which changed a codon from Gln to a stop codon
(P.Q155X). This mutation cosegregated with all affected individuals and was not observed in any unaffected family
member or 100 normal, unrelated individuals.
Conclusions: This study identified a mutation in CRYBB2 in a large Chinese family with autosomal dominant progressive
polymorphic congenital coronary cataracts. These results provide evidence that CRYBB2 is a pathogenic gene for
congenital cataracts; at the same time, congenital cataracts are a clinically and genetically heterogeneous lens condition.
Cataracts are an opacity of the lens that leads to loss of
vision, and even blindness, and can be congenital or acquired,
unilateral or bilateral [1]. Idiopathic, hereditary syndromes
(Down  syndrome  and  Rubinstein-Taybi  syndrome),  and
intrauterine  infections  (congenital  measles)  can  cause
congenital cataracts, and traumatic, metabolism (high blood
pressure), and some substances (alcohol and smoking) can
cause acquired cataracts [2-4].
Congenital  cataracts  are  a  clinically  and  genetically
heterogeneous  lens  condition  responsible  for  a  significant
proportion of childhood visual impairment and blindness [5,
6]. They can occur in an isolated fashion or as a component
of  a  multi-system  disorder.  Non-syndromic  congenital
cataracts have an estimated incidence of 1–6 per 10,000 live
births [7-10]. Although congenital cataracts are much less
common than age-related cataracts, they are still responsible
for approximately 10% of childhood blindness worldwide
[11].
Since  the  first  description  of  the  cosegregation  of
inherited cataracts with the Duffy blood group locus, more
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than 30 loci have been mapped through linkage analysis and
17 genes have been characterized [12,13]. These genes can be
considered  in  five  groups,  ten  genes  encoding  crystallins
(CRYAA,CRYAB,CRYBA1/
A3,CRYBA,CRYBB1,CRYBB2,CRYBB3,CRYGC,CRYGD,
and the CRYGs), three encoding membrane transport proteins
(MIP,GJA3, and GJA8), one encoding cytoskeletal proteins
(BSFP2), three encoding transcription factors (HSF4,MAF,
and PITX3), and one encoding a lens intrinsic membrane
protein [14-16].
Len crystallins are subdivided into α, β, and γ crystallins
and  constitute  more  than  80%–90%  of  the  water-soluble
structural proteins present in the vertebrate crystallin lens
[17]. α-Crystallins are heat shock proteins that function as
molecular chaperones while γ- and β-crystallins are members
of a superfamily of microbial stress proteins, which share a
common structural feature of four ‘Greek key’ motifs, two (1
and 2) in the NH2- and two (3 and 4) in the COOH-terminal
domain [18]. Modifications of crystallins may disrupt their
normal structure in the lens and cause cataracts [19].
Here, we report a large, five-generation Chinese family
with  autosomal  dominant  progressive  polymorphic
congenital coronary cataracts. Linkage analysis mapped the
disease gene to 22q11.2–12.2, and a nonsense mutation (475C
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750→ T) in CRYBB2 was identified in this family, resulting in the
substitution of a codon for the conserved amino acid, Gln, with
a stop codon. Clinical and ophthalmologic examinations were
conducted on family members in detail; all affected members
show different clinical features.
METHODS
Clinical  evaluation  and  DNA  specimens:  A  large,  five-
generation  family  with  non-syndromic  progressive
polymorphic congenital coronary cataracts was recruited at
the Beijing Tongren Eye Center, Capital Medical University,
Beijing, China. Informed consent was obtained from each
participant, consistent with the Declaration of Helsinki. The
phenotype  was  documented  by  slit-lamp  photography.
Genomic  DNA  was  extracted  from  peripheral  blood
leukocytes using standard protocols.
Genotyping:  Polymerase  chain  reactions  (PCRs)  were
performed with microsatellite markers close to candidate loci
associated with autosomal congenital cataracts. PCR products
from  each  DNA  sample  were  separated  on  a  6%
polyacrylamide gel and analyzed. Pedigree and haplotype data
were  managed  using  the  Cyrillic  software  (version  2.1).
Exclusion analysis was performed by allele sharing in affected
individuals [20].
Linkage analysis: A two-point linkage was calculated with the
LINKAGE  package  (version  5.1).  Autosomal  dominant
cataracts  were  analyzed  with  full  penetrance  and  a  gene
frequency of 0.001. The allele frequencies for each marker
were assumed to be equal in both genders. The marker order
and  distances  between  the  markers  were  taken  from  the
NCBI and GDB databases.
DNA sequencing: Individual exons of the β-crystallin gene
cluster were amplified by PCR using primer pairs [21]. PCR
products  were  sequenced  using  an  ABI3730  Automated
Sequencer (PE Biosystems, Foster City, CA).
Denaturing  high-performance  liquid  chromatography:
Denaturing  high-performance  liquid  chromatography
(DHPLC)  was  used  to  screen  the  mutation  identified  in
Figure 1. Slit lamp photographs of an affected individual (III:23).
The photographs of the affected individual III:23 showed that the
opacities  were  coronary  cataracts  with  punctate,  asteroidal,  and
nuclear opacities. There were pulverulent opacities in the perinuclear
areas of the right lens while pulverulent opacities in the left lens were
lighter. They were also more coronal in the left eye.
affected  patients,  other  family  members,  and  100  normal
control subjects in exon 6 of CRYBB2 using a commercial
system (Wave DHPLC; Transgenomic, San Jose, CA).
RESULTS
Clinical data: The proband was a 33-year-old male (III: 23)
who had bilateral cataracts. From the age of 12 or 13, he had
light apprehension and ambiguous visual clinical features.
The condition became serious at the age of 25. Slit-lamp
examination  (III:  23)  showed  grayish/bluish  punctate
opacification in the cortex. A large number of spindle-shaped
and  oval  punctate  opacities  were  directed  radially  in  the
periphery, just like coronal cataracts. The clinical features of
the left and right lenses showed some differences. No systemic
or other ocular anomalies were observed in the patient.
This  five-generation  family  included  17  affected
individuals with congenital special-type coronary cataracts
(Figure 1) and 34 unaffected individuals. The diagnosis was
confirmed by ophthalmologists. The clinical diagnosis of the
family was progressive polymorphic coronary cataracts with
punctate,  asteroidal,  and  nuclear  opacities.  Each  of  the
affected individuals showed a somewhat different phenotype;
in some affected subjects, star-like opacification was present
in the upper side of the posterior pole (Table 1). There was no
history of other ocular or systemic abnormalities in the family.
Linkage  and  haplotype  analysis:  The  CRYBB2  gene  on
chromosome 22 was linked to this family’s disease while other
candidate genes were excluded by allele sharing and linkage
Figure  2.  Pedigree  and  haplotype  of  the  cataract  family.  Five-
generation  pedigree  segregates  autosomal  dominant  progressive
polymorphic coronary cataracts. Haplotyping showed segregation
with two microsatellite markers on 22q. Squares and circles indicate
males and females, respectively. Blackened symbols and bars denote
affected status.
Figure 3. DNA sequence chromatograms of the P.Q155Χ mutation
in CRYBB2. Forward sequence analysis of the normal and affected
sequence of exon 6 of the CRYBB2 gene in this family is shown. The
C→T transition at position 475 resulted in the P.Q155Χ mutation.
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751analysis.  Significant  linkage  was  found  with  markers,
D22S303 and D22S1167; the maximum LOD score was 2.11
(at θ=0). Haplotype analysis showed that the phenotype was
localized at chromosome 22q11.2–12.2 flanked by markers,
D22S303 and D22S1167 (Figure 2, Table 2).
Mutation  analysis  for  CRYBB1,  CRYBB2,  CRYBB3,  and
CRYBA4: Direct cycle sequencing of the amplified fragments
of CRYBB2 in two affected individuals identified a single base
alteration,  C.C475T  (Figure  3A),  in  exon  6  of  CRYBB2
(NM_000496), resulting in a substitution of a Gln codon with
a  stop  codon  (P.Q155X).  The  remainder  of  the  coding
sequence showed no other change.
Denaturing HPLC: Denaturing HPLC analysis confirmed this
mutation (Figure 4), which cosegregated with all affected
individuals  in  the  family.  Further,  this  mutation  was  not
observed in any of the unaffected family members or the 100
normal controls.
DISCUSSION
We identified a mutation, P.Q155X, in CRYBB2 in a large,
five-generation  Chinese  family  with  autosomal  dominant
progressive polymorphic congenital coronary cataracts. The
disease gene was linked to 22q11.2–12.2 with a maximum
LOD score of 2.11 spanning the β-crystallin gene cluster,
TABLE 1. CLINICAL FEATURES OF AFFECTED FAMILY MEMBERS.
Number Age Gender Onset age Surgery age Clinical features
II1 73 Female 20 30 Aphakia, after cataract surgery
II3 61 Male 14–15 30 Aphakia, after cataract surgery
III1 53 Male 30 Bilateral coronary,punctate, asteroidal (above the posterior pole)
cataracts
III2 50 Male 20 Bilateral coronary, punctate cataracts; gray opacity in partial
coronary area
III3 42 Female 15 25 Aphakia, after cataract surgery
III4 47 Female 16–17 32 Right coronary, punctate, asteroidal (posterior pole) cataracts; left
after cataract surgery
III5 36 Female 14–15 27 Aphakia, after cataract surgery
III20 40 Female 13 22 After bilateral phacoemulsification and intraocular lens
implantation
III21 37 Female 10 29 After bialateral phacoemulsification and intraocular lens
implantation
III22 35 Male 12 Bilateral punctate, asteroidal (above the posterior pole) cataracts
III23 33 Male 12 33 Proband
IV1 25 Male 12 Bilateral punctate, asteroidal (above the posterior pole) cataracts
IV4 22 Female 12 Bilateral punctate, asteroidal (above the posterior pole) cataracts
IV8 19 Male 10 Bilateral coronary, punctate cataracts
IV10 24 Female 15 Bilateral coronary, inverted T-shaped (posterior pole) cataracts
IV15 13 Male Bilateral sparse punctate, asteroidal (above the posterior pole)
cataracts
IV16 6 Male Sparse punctate opacities
Before the age of 10, no clinical features were manifest (IV16); punctate opacification was primarily scattered in the lens
perimeter, causing almost no influence on the life of the affected individuals. In adolescence, affected individuals showed
ambiguous visual clinical features. At about the age of 30, the clinical features became serious. Two affected family members
(III4, III23) had different clinical features between their two lenses; III1, III2, III22, and IV10 had different clinical features
from each other. The clinical features of III22, IV1, and IV4 were similar.
TABLE 2. TWO-POINT LOD SCORES FOR LINKAGE BETWEEN CATARACT LOCUS AND CHROMOSOME 22 MARKERS
Marker
LOD scores by recombination fraction (θ)
0 0.04 0.09 0.14 0.19 0.24 0.29
D22S303 2.11 1.98 1.82 1.65 1.47 1.27 1.07
D22S1167 1.2 1.13 1.04 0.94 0.84 0.73 0.61
The highest observed LOD score was 2.11 (θ=0) for marker D22S303.
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752which includes CRYBB1, CRYBB2, CRYBB3, and CRYBA4.
Mutation analysis of the candidate gene detected a mutation,
P.Q155X,  in  CRYBB2  that  cosegregated  with  the  disease
phenotype in all affected individuals but was not present in
the unaffected family members or the 100 normal control
subjects.  Clinical  and  ophthalmologic  examinations  were
conducted on family members in detail; all affected members
show different clinical features, and some affected members
show different clinical features between the two lenses.
Development of the lens is intrinsically linked to the
development  of  the  anterior  segment;  a  transcriptional
cascade is involved in early lens development, through Pax6
expression followed by expression of Mafs, Soxs, and Prox1,
resulting  in  the  initiation  of  lens  cell  differentiation  and
crystallin  expression  [22-27].  The  β-crystallins  are  major
constituents of the mammalian lens where they associate into
dimers,  tetramers,  and  higher  oligomers.  The  appropriate
association  of  crystallins  into  higher-order  complexes  is
critical to the maintenance of lens transparency and a high
refractive index [28]. Opacification in the lens can hinder light
from focusing on the retina during key stages of development
and lead to permanent visual impairment [29].
CRYBB2 consists of six exons encoding a predicted 205
amino acid protein. The first exon is not translated, the second
exon encodes the NH2-terminal extension, and the subsequent
four exons are responsible for one ‘Greek key’ motif each
[30].  The  α-,  β-,  and  γ-crystallins  form  heterogeneous
oligomers in the lens and have molecular weights ranging
from 40 to 200 kDa [31]. So far, there have been eight reports
Figure  4.  Denaturing  high-performance  liquid  chromatography
results of wild type and mutated CRYBB2. DHPLC results show
variant traces for CRYBB2 compared with the wild type (WT) trace.
The profile in blue is the mutant protein; the profile in red is the wild
type protein.
in the literature of CRYBB2 gene mutations causing congenital
cataracts [32-39]. In addition to Pauli et al. [32], who reported
a German family with a mutation in exon5 (p.D128V) which
caused  a  nuclear  cataract  with  an  additional  ring-shaped
cortical opacity and Yao et al. [35] who reported a Chinese
family with a mutation in exon 6 (p.Q155 X) which caused
highly variable white opacities distributed in the nucleus and
cortex, which included pulverulent, dot, strip, star-like and
sheet shapes, the clinical features of the other reports were
relatively simple (include sutural cataracts, cerulean cataracts
and Coppock-like cataracts). This is the sixth reported case of
a C.C475T mutation causing congenital cataracts, providing
further  evidence  that  CRYBB2  is  a  pathogenic  gene  for
congenital  cataracts  and  that  this  site  is  a  hot  spot  for
CRYBB2 mutation.
The  clinical  diagnosis  in  the  family  was  coronary
cataracts  with  punctate,  asteroidal,  and  nuclear  opacities.
Opacification of the lens in affected individuals was bilateral.
Each of the affected individuals showed a somewhat different
phenotype.  In  some  affected  subjects,  the  star-like
opacifications were present at different sites in the posterior
pole. Some affected like the proband (pulverulent opacities in
the  perinuclear  areas  of  the  right  lens  while  pulverulent
opacities in the left lens were lighter, and in the left lens, they
were more coronal) show different clinical features between
the two lenses.
Before the age of 10, no clinical features were manifest
in  the  affected  individuals,  although  there  was  punctate
opacification scattered mainly in the lens perimeter, but this
had almost no effect on their lives. In adolescence, affected
individuals showed ambiguous visual clinical features, and at
about the age of 30, the clinical features became serious. Each
of  the  affected  individuals  showed  a  somewhat  different
phenotype.  In  some  affected  subjects,  the  star-like
opacifications were present in the upper side of the posterior
pole. The opacification style in each affected individual was
not alike; some were star-like and some were of an inverted
T-shape. These observations provide evidence that congenital
cataracts are a clinically heterogeneous lens condition.
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